IN VIVO is the premier resource for life science business strategy, providing in-depth analysis of the biopharma, medtech, and diagnostics industries in one package. Every month it delivers unparalleled deals analysis, interesting narratives, insider interviews, and think pieces to help readers make sense of the rapidly changing health care environment.
IN VIVO strives to unveil the “so what” underpinning current industry events in clear, precise language so that readers can make proactive rather than reactive business decisions. This knowledge helps companies broker deals with confidence and identify opportunities that competitors may miss. Unlike other business publications, IN VIVO delves into the complexities behind the headlines and sound bites, searching for meaning in the available data. The magazine’s award-winning analysts compile the information in an accessible format that outlines the implications for you and your company.
IN VIVO delivers:
- Revealing, in-depth coverage of your competitors’ strategies
- Incisive projections of future industry trends and their implications for your business
- Expert analysis of key industry developments
- Exclusive interviews with top industry executives and analysts
- Rich deals data from around the world
- In-depth examination of dealmaking, marketing, R&D, regulatory, and finance strategies — those that were successful and those that missed the mark
Your IN VIVO subscription will include:
- 11 monthly issues: Including a combined July-August issue
- Email updates: Twice-weekly updates delivered to your inbox
- Online access: Searchable access to a rolling 90 or 365 days of content
- Archives: Available access to the information you need from our complete archive
- Topical RSS Feeds
- Daily online news resource: A free subscription to Health News Daily, our online resource for news in pharmaceuticals, biotechnology, medical devices and Washington health policy
Subscription Terms
Subscription Options
Buy Now
Includes:
Email newsletter with latest headlines, breaking news alerts, and access to IN VIVO — the premier strategic business resource for the biopharma, medtech, and diagnostics industries.
Multiple users/site features: Contact Deanna Flanick at +1-908-547-2141 or D.Flanick@Elsevier.com.